Baytril Max 100 mg/ml Solution for Injection for Pigs

Main information

  • Trade name:
  • Baytril Max 100 mg/ml Solution for Injection for Pigs
  • Available from:
  • Bayer plc
  • Prescription type:
  • POM-V
  • Medicine type:
  • Veterinary

Localization

  • Available in:
  • United Kingdom
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Pigs

Status

  • Source:
  • VMD
  • Authorization date:
  • 2011-09-05

Documents

9-12-2015

Orphan designation: Imatinib mesilate, for the: Treatment of myelodysplastic / myeloproliferative diseases

On 23 December 2005, orphan designation (EU/3/05/340) was granted by the European Commission Novartis Europharm Limited, United Kingdom, for imatinib mesilate for the treatment of myelodysplastic / myeloproliferative diseases. Please note that this product was withdrawn from the Community Register of designated orphan medicinal products in April 2012 on request of the sponsor.

Europe - EMA - European Medicines Agency

29-7-2015

Scientific Opinion on Dietary Reference Values for phosphorus

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies derived Dietary Reference Values (DRVs) for phosphorus. The Panel considered data from balance studies, losses of phosphorus from the body and intestinal absorption for possible use in a factorial approach, and studies on phosphorus intake and long-term health outcomes. The Panel concluded that these data were insufficient for setting D...

Europe - EFSA - European Food Safety Authority EFSA Journal

29-7-2015

Scientific Opinion on the safety and efficacy of Biosprint(R) (Saccharomyces cerevisiae MUCL 39885) for minor ruminant species for meat and milk production

EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) Biosprint® is a zootechnical feed additive consisting of a dried preparation of a strain of Saccharomyces cerevisiae. It is already authorised for use in feed for piglets, cattle for fattening, dairy cows, horses and sows. The applicant has now requested that the product be authorised for use as a zootechnical additive (functional group: gut flora stabilisers) in diets for dairy buffaloes, dairy sheep and dairy go...

Europe - EFSA - European Food Safety Authority EFSA Journal

29-7-2015

Scientific Opinion on Dietary Reference Values for magnesium

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies (NDA) derived Dietary Reference Values (DRVs) for magnesium. The Panel considers that Average Requirements (ARs) and Population Reference Intakes (PRIs) for magnesium cannot be derived for adults, infants or children, and therefore defines Adequate Intakes (AIs), based on observed intakes in healthy populations in the European Union (EU...

Europe - EFSA - European Food Safety Authority EFSA Journal

28-7-2015

Conclusion on the peer review of the pesticide risk assessment of the active substance thifensulfuron-methyl

European Food Safety Authority The conclusions of the European Food Safety Authority (EFSA) following the peer review of the initial risk assessments carried out by the competent authority of the rapporteur Member State the United Kingdom, for the pesticide active substance thifensulfuron-methyl are reported.  The context of the peer review was that required by Commission Regulation (EU) No 1141/2010 as amended by Commission Implementing Regulation (EU) No 380/2013. The conclusions were reach...

Europe - EFSA - European Food Safety Authority EFSA Journal

28-7-2015

Scientific Opinion on Flavouring Group Evaluation 208 Revision 1 (FGE.208Rev1): Consideration of genotoxicity data on representatives for 10 alicyclic aldehydes with the α,β-unsaturation in ring / side-chain and precursors from chemical subgroup 2.2 of

EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF) The EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids was requested to evaluate the genotoxic potential of flavouring substances from subgroup 2.2 of FGE.19 in the Flavouring Group Evaluation 208 Revision 1 (FGE.208Rev1). The Flavour Industry has provided additional genotoxicity studies on p-mentha-1,8-dien-7-al [FL-no: 05.117], the representative substance for FGE.19 subgroup 2.2. T...

Europe - EFSA - European Food Safety Authority EFSA Journal

28-7-2015

Modification of the existing maximum residue levels for fenoxycarb in peaches and olives

European Food Safety Authority In accordance with Article 6 of Regulation (EC) No 396/2005, the evaluating Member State (EMS), France, received an application from Syngenta Agro S.A.S. to modify the existing maximum residue levels (MRLs) for the active substance fenoxycarb in peaches and olives. In order to accommodate for the intended uses of fenoxycarb, France proposed to raise the value of the existing MRL of 1 mg/kg (both peaches and olives) to 1.5 mg/kg in peaches and 3.0 mg/k...

Europe - EFSA - European Food Safety Authority EFSA Journal

28-7-2015

Reasoned opinion on the review of the existing maximum residue levels (MRLs) for acrinathrin according to Article 12 of Regulation (EC) No 396/2005

European Food Safety Authority According to Article 12 of Regulation (EC) No 396/2005, the European Food Safety Authority (EFSA) has reviewed the Maximum Residue Levels (MRLs) currently established at European level for the pesticide active substance acrinathrin. In order to assess the occurrence of acrinathrin residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Regulation (EC) No 1107/2009 as well as the Europe...

Europe - EFSA - European Food Safety Authority EFSA Journal

27-7-2015

Orphan designation: Obinutuzumab, for the: Treatment of marginal zone lymphoma

Europe - EMA - European Medicines Agency

27-7-2015

Orphan designation: Obinutuzumab, for the: Treatment of follicular lymphoma

Europe - EMA - European Medicines Agency

27-7-2015

Orphan designation: Trehalose, for the: Treatment of spinocerebellar ataxia

Europe - EMA - European Medicines Agency

27-7-2015

100% Natural Sunscreen SPF 30 (2015-07-21)

Canada - Health Canada

29-7-2015

News and press releases: Calls for civil society members for two EMA committees

Expressions of interest to represent civil society at PRAC and CAT to be submitted to European Commission by 30 September 2015

Europe - EMA - European Medicines Agency

29-7-2015

ATRACURIUM BESYLATE Injection, Solution [Aurobindo Pharma Limited]

Updated Date: Jul 29, 2015 EST

US - DailyMed

28-7-2015

News and press releases: EMA to encourage use of scientific advice for post-authorisation safety studies

12-month pilot will support design of high-quality safety studies

Europe - EMA - European Medicines Agency

28-7-2015

EPSOM SALT (Magnesium Sulfate) Granule, For Solution [Vi-Jon]

Updated Date: Jul 28, 2015 EST

US - DailyMed

28-7-2015

METRONIDAZOLE Solution [B. Braun Medical Inc.]

Updated Date: Jul 28, 2015 EST

US - DailyMed

28-7-2015

DR CELLINME SKIN CARE AMPOULE (Niacinamide) Solution [Dr.Gene Co.,Ltd]

Updated Date: Jul 28, 2015 EST

US - DailyMed

28-7-2015

FIRST AID ANTISEPTIC (Povidone-Iodine) Solution [Target Corporation]

Updated Date: Jul 28, 2015 EST

US - DailyMed

28-7-2015

BACTERIOSTATIC WATER (Water) Solution [Hospira, Inc.]

Updated Date: Jul 28, 2015 EST

US - DailyMed

28-7-2015

PYRIDOXINE HYDROCHLORIDE Injection, Solution [Fresenius Kabi USA, LLC]

Updated Date: Jul 28, 2015 EST

US - DailyMed

27-7-2015

News and press releases: Fast track routes for medicines that address unmet medical needs

Launch of two-month public consultations on revised guidelines on accelerated assessment and conditional marketing authorisation

Europe - EMA - European Medicines Agency

27-7-2015

DIPHENHYDRAMINE HYDROCHLORIDE Injection [REMEDYREPACK INC. ]

Updated Date: Jul 27, 2015 EST

US - DailyMed

27-7-2015

PRALUENT (Alirocumab) Injection, Solution [Sanofi-Aventis U.S. LLC]

Updated Date: Jul 27, 2015 EST

US - DailyMed

27-7-2015

CEFTRIAXONE AND DEXTROSE (Ceftriaxone) Injection, Solution [B. Braun Medical Inc.]

Updated Date: Jul 27, 2015 EST

US - DailyMed

27-7-2015

NALBUPHINE HYDROCHLORIDE Injection, Solution [Hospira, Inc.]

Updated Date: Jul 27, 2015 EST

US - DailyMed

27-7-2015

PFIZERPEN (Penicillin G Potassium) Powder, For Solution [Roerig]

Updated Date: Jul 27, 2015 EST

US - DailyMed

24-7-2015

News and press releases: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2015

Ten new medicines recommended for authorisation in the EU, and first malaria vaccine receives positive scientific opinion for use outside the EU

Europe - EMA - European Medicines Agency

24-7-2015

News and press releases: First malaria vaccine receives positive scientific opinion from EMA

Mosquirix to be used for vaccination of young children, together with established antimalarial interventions

Europe - EMA - European Medicines Agency

24-7-2015

News and press releases: Praluent recommended for approval to lower cholesterol

Medicine to offer therapy for patients unable to control high cholesterol with currently available treatment

Europe - EMA - European Medicines Agency

24-7-2015

News and press releases: EMA recommends approval of treatment for attention deficit hyperactivity disorder

Intuniv to be used in combination with comprehensive behavioural treatment in children and adolescents

Europe - EMA - European Medicines Agency

24-7-2015

EASTER SCALP (Pyrithione Zinc) Solution [WECOSMETICS Co.]

Updated Date: Jul 24, 2015 EST

US - DailyMed

24-7-2015

LEVETIRACETAM Solution [Morton Grove Pharmaceuticals, Inc.]

Updated Date: Jul 24, 2015 EST

US - DailyMed

24-7-2015

TRICITRASOL (Trisodium Citrate Dihydrate) Solution [Citra Labs LLC]

Updated Date: Jul 24, 2015 EST

US - DailyMed

24-7-2015

EASTER STEM CELL HAIR PERFECTION 22 (Dimethicone) Solution [WECOSMETICS Co.]

Updated Date: Jul 24, 2015 EST

US - DailyMed

23-7-2015

News and press releases: Stimulating the development of medicines for children

EMA’s revision of class waiver list expected to push the exploration of many more medicines for use in children

Europe - EMA - European Medicines Agency

Other products with the same active ingredient

Other products from the same company